MedPath

Effect of organic selenium on the treatment of breast cancer-related lymphedema

Phase 3
Conditions
Breast Cancer-Related Lymph edema.
Postprocedural disorders of circulatory system, not elsewhere classified
I 97
Registration Number
IRCT20131009014957N12
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
50
Inclusion Criteria

The first or second stage of breast cancer-related lymphedema
Unilateral arm lymphedema
Body mass index between 18.5 to 30

Exclusion Criteria

The presence of bilateral lymphedema
The existence of known metastasis
The existence of diseases leading to edema such as heart and kidney failure.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
imb circumference (arm, forearm, wrist). Timepoint: Baseline and 60 days after the intervention. Method of measurement: Tape meter.;Skinfold thickness. Timepoint: Baseline and 60 days after the intervention. Method of measurement: Using the specified formula.;Quality of life score. Timepoint: Baseline and 60 days after the intervention. Method of measurement: WHOQOL-BREF standard quality of life questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath